Objectives: To identify the "core domains" (i.e., patient outcomes, health-related conditions, or aspects of health) that relevant stakeholders agree are essential to assess in all clinical research studies evaluating the outcomes of acute respiratory failure survivors after hospital discharge. Design: A two-round consensus process, using a modified Delphi methodology, with participants from 16 countries, including patient and caregiver representatives. Prior to voting, participants were asked to review 1) results from surveys of clinical researchers, acute respiratory failure survivors, and caregivers that rated the importance of 19 preliminary outcome domains and 2) results from a qualitative study of acute respiratory failure survivors' outcomes after hospital discharge, as related to the 19 preliminary outcome domains. Participants also were asked to suggest any additional potential domains for evaluation in the first Delphi survey. Setting: Web-based surveys of participants representing four stakeholder groups relevant to clinical research evaluating postdischarge outcomes of acute respiratory failure survivors: clinical researchers, clinicians, patients and caregivers, and U.S. federal research funding organizations. Subjects: None. Interventions: None. Measurements and Main Results: Survey response rates were 97% and 99% in round 1 and round 2, respectively. There were seven domains that met the a priori consensus criteria to be designated as core domains: physical function, cognition, mental health, survival, pulmonary function, pain, and muscle and/or nerve function. Conclusions: This study generated a consensus-based list of core domains that should be assessed in all clinical research studies evaluating acute respiratory failure survivors after hospital discharge. Identifying appropriate measurement instruments to assess these core domains is an important next step toward developing a set of core outcome measures for this field of research. (Crit Care Med 2017; 45:1001-1010 
(NHLBI); Society of Critical Medicine; American Thoracic Society; and the Multisociety Task Force for Critical Care Research, have recommended prioritizing research on the outcomes of ICU survivors after hospital discharge (6) (7) (8) (9) (10) (11) (12) . Although there have been more than 300 original research publications on ICU survivors' outcomes after hospital discharge since 2000 (13) , comparing, synthesizing, and interpreting this work have been difficult (14) . A recent scoping review found that 250 unique measurement instruments were used between 1970 and 2013 to assess ICU survivors' outcomes after hospital discharge (13) making comparisons between studies difficult. Additionally, the psychometric properties of many of the instruments used in these studies have not been well-evaluated among ICU survivors (15) .
A core outcome set (COS) is a minimum collection of outcome measures reported in all studies within a specific field (16, 17) . Importantly, a COS does not prevent investigators from collecting data on additional outcomes. Instead, a COS sets a minimum standard to ensure that the most basic and crucial outcomes in a given field are consistently assessed in the same way to facilitate comparisons, meta-analyses, and prevent bias from selective outcome reporting (18, 19) . In developing a COS, relevant stakeholders participate in a deliberate and systematic process to identify measurement instruments that 1) evaluate vitally important outcome domains, 2) have sound measurement properties, and 3) are accessible and feasible for the proposed purpose (20) . As of September 2016, there are seven projects registered with the Core Outcome Measures in Effectiveness Trials (COMET) Initiative (http://www.cometinitiative.org/) to develop COS related to critical care (21) .
Before selecting measurement instruments for a COS, there must be consensus on "core domains," defined as patient outcomes, health-related conditions, or aspects of health, that are essential to evaluate within a clinical field (20, 22) . The process of identifying core domains focuses on "what" types of outcomes to measure (e.g., muscle strength), before a subsequent step of determining "how" to measure these outcomes (e.g., hand-grip dynamometry). Despite the hundreds of measurement instruments used to evaluate ICU survivors, it is likely that valid, reliable, and accessible instruments for measuring some core domains do not yet exist. However, focusing on those outcomes that are truly essential to evaluate in all clinical research studies of ICU survivors, regardless of current availability and feasibility, helps set long-term goals and identify methodologic research priorities within a field. Hence, our objective was to identify the core domains for clinical research evaluating the outcomes of survivors of acute respiratory failure (ARF), including acute respiratory distress syndrome, after hospital discharge using a rigorous consensus methodology and an international panel of relevant stakeholders.
METHODS
We conducted a two-round, international consensus development process using a rigorous modified Delphi methodology with web-based communication and anonymous voting. The Delphi consensus methodology uses expert opinion to address questions for which empirical data are unavailable or inadequate (23) . Recently, the Delphi method has been used to develop COS for research on conditions as diverse as multiple sclerosis (24) , stroke (25) , and preterm birth (26) . More information about Delphi methodology, identifying outcome domains, and survey development is available in Table E1 (Supplemental Digital Content 1, http://links.lww.com/CCM/ C588). We have reported this research study in accordance with current recommendations for establishing COS via the Delphi process (17, 27) . A copy of the complete study protocol can be accessed at http://www.improvelto.com/. This project was registered with COMET Initiative (http://www.comet-initiative.org/studies/details/360) and funded by NHLBI (Grant R24HL111895, Improving Long-Term Outcomes Research for Acute Respiratory Failure-see www.improvelto.com).
Recruitment of the Delphi Panel
We sought to recruit a diverse panel with emphasis on end users of the COS (i.e., clinical researchers evaluating patient outcomes after ARF). Based on methodologic guidance from the Patient-Centered Outcomes Research Institute (28), Agency for Healthcare Research and Quality (29) , and Outcome Measures in Rheumatology (20) , four stakeholder groups relevant to clinical research evaluating postdischarge outcomes of ARF survivors were identified for this consensus project: 1) critical care clinical researchers, 2) clinicians caring for ARF patients/survivors, 3) ICU survivors or caregivers of ICU survivors, and 4) representatives of federal organizations that fund ARF clinical research. Given that the target end users were clinical researchers, we focused on an international recruitment strategy, as described in Tables E1 and E2 (Supplemental Digital Content 1, http://links.lww.com/CCM/ C588). For recruiting clinicians, patients, and caregivers to the consensus process, we focused on representatives from the United States, United Kingdom, Australia, and Canada. These were the top four English-speaking countries represented in a scoping review of outcome measurement in ICU survivorship research (13) and participants will be asked to review individual English-language measurement instruments in a future study. Recruitment methods and response rates by stakeholder group as well as the list of panel members are provided in Tables E1 and E2 (Supplemental Digital Content 1, http:// links.lww.com/CCM/C588). Invitation e-mails to all invited stakeholder representatives explained that survey completion would serve as informed consent and specified the need for commitment to, and timely participation in, the entire Delphi process. The Qualtrics online survey platform was used to collect demographic information about expert panel members, and DelphiManager software (COMET Initiative, Liverpool, United Kingdom) was used to administer the rounds 1 and 2 surveys. The institutional review board of Johns Hopkins University approved this study.
Modified Delphi Methodology
At the start of both Delphi rounds, participants were reminded of the goal of the consensus project and the definition of a core domain. Each domain was rated using the Grading of Recommendations Assessment, Development and Evaluation scale (30) , which is a nine-point scale that is commonly divided into three categories for COS projects: not important (1-3), important but not critical (4) (5) (6) , and critical (7) (8) (9) . Additionally, panel members were provided an "unable to score" response and instructed to use it if they did not feel comfortable rating any specific domain. Consensus for designation as a core domain was defined a priori as greater than or equal to 70% of responses rating the domain as "critical" (i.e., a score ≥ 7) and less than or equal to 15% of responses rating the domain as "not important" (i.e., score ≤ 3). This consensus definition has been used in other Delphi studies (31) (32) (33) (34) and ensured that a domain would not achieve consensus if a minority stakeholder group (i.e., patients/caregivers or clinicians) commonly rated it as not important. All steps in the Delphi process took place on-line, and the anonymity of panel members was maintained throughout.
Round 1
Round 1 started on January 8, 2016. Prior to voting, participants were asked to review 1) results from surveys of clinical researchers, ARF survivors, and caregivers that rated the importance of 19 preliminary outcome domains and 2) results from a qualitative study of ARF survivors' outcomes after hospital discharge, as related to the 19 preliminary outcome domains. The round 1 survey asked Delphi panel members to rate the importance of each of the 19 preliminary domains without consideration of the availability, ease of use, feasibility, or measurement properties of any available instruments to assess the domain. Participants who scored the cognitive function domain as critical (score ≥ 7) were then asked to rate the nine cognitive function subdomains, as described above. The survey asked an openended question about other potential core domain(s) missing from the preliminary list. Panel members were given the option to provide text-based comments or feedback after scoring each domain and at the end of the survey. To help prevent any potential bias from response order effects (i.e., primacy and recency effects [35] ), the 19 preliminary domains were presented in one of four unique orders randomly generated using R statistical software (version 3.0.1; R Development Core Team, Vienna, Austria). Panel members were asked to complete the round 1 survey within 7 days of receipt and encouraged to contact the research team if any of the following were needed: clarification regarding the instructions, additional information about the Delphi process, technical support, or additional time to complete the survey. Panel members who had not responded after 7 days received up to three reminder e-mails, and after 2 weeks, nonrespondents were contacted by phone or text message to encourage completion of the survey.
Round 2
All panel members were invited to complete the round 2 survey regardless of round 1 participation. The documents from round 1 (as described above) were provided with round 2. Within round 2, histograms of ratings for each domain aggregated from all round 1 participants, as well as stratified by each stakeholder group, were displayed. Participants who completed round 1 also were shown their personal round 1 rating alongside group ratings. The round 2 survey asked participants to rerate the 19 preliminary domains as well as eight new domains proposed during round 1, and the nine cognitive subdomains. As in round 1, panel members were instructed to rate the importance of each domain in round 2 without consideration of the availability, ease of use, feasibility, or measurement properties of any available instruments to assess the domain. Panel members were asked to complete the round 2 survey within 72 hours. Those who had not responded after 7 days received up to four reminder e-mails, and after 2 weeks, nonrespondents were contacted by phone or text message.
Statistical Reporting
Response rates were defined as the proportion of recruited panel members who completed each survey. Survey responses were summarized with descriptive statistics using SAS version 9.4 (SAS Institute Inc., Cary, NC).
RESULTS
The expert panel had 77 participants, comprised of 35 clinical researchers (45%), 19 clinicians and representatives of professional associations (25%), 19 patients/caregivers (25%), and four representatives (5%) of U.S. federal research funding organizations ( Table 1) . There were 42 panel members (55%) from outside of the United States, and 36 (47%) were female. The median years of professional experience (excluding patient and caregiver stakeholder group) was 14.5 (interquartile range [IQR], 9-21).
In round 1, 74 of 76 panel members (97%) responded, with nonresponse from two clinical researchers. Among the 19 outcome domains provided, seven (37%) met consensus criteria as core domains: physical function, cognition, mental health, survival, pulmonary function, pain, and muscle and/or nerve function ( Table 2) . Support for individual domains was similar across stakeholder groups except two domains that had substantially higher support from patients/caregivers versus other stakeholder groups: financial impact on the patient (78% vs 38%) and healthcare resource utilization (67% vs 41%). Conversely, the domain of survival was rated as critical by 94% of clinical researchers and only 50% of patients/caregivers. Among the nine cognitive subdomains, seven (78%) met the consensus criteria. Panel members suggested eight additional domains for consideration in round 2: fatigability/endurance, susceptibility to repeated infections, renal function, self-efficacy/management, management of complex medication regimens, resilience, hearing, and loss of taste (Fig. 1) .
The results of round 2 are summarized in Tables 3 and 4 . The overall response rate was 99% (75/76), with one patient/caregiver not responding. Each of the seven domains meeting consensus criteria in round 1 was rated as critical (score ≥ 7) by even larger proportions of the panel in round 2. None of the eight additional domains suggested by panel members in round 1 met the consensus criteria. Among the nine cognitive subdomains, eight (89%) met the consensus criteria, with all cognitive subdomains receiving similar levels of support and 13 (18%) panel members selecting unable to score for at least one domain (Table  4) . Patients/caregivers (vs other stakeholder groups) continued to more strongly rate two domains as critical for inclusion: financial impact on the patient (88% vs 48%) and healthcare resource utilization (71% vs 50%). However, with only 57% and 55%, respectively, of all panel members rating these domains as critical, they did not meet the consensus criteria as core domains. As in round 1, support for the survival domain remained much greater among clinical researchers (100%) than patients/caregivers (59%). The distributions of responses for each domain in round 2 are displayed in Table E3 (Supplemental Digital Content 1, http://links.lww.com/CCM/C588). The consensus criteria for inclusion as a core domain were defined as ≥ 70% of all panel members rating a domain ≥ 7 and no more than 15% rating the domain ≤ 3 on a nine-point scale. Domains are ordered by the proportion of panel members rating the domain ≥ 7. 
DISCUSSION
This study used a two-round, modified Delphi consensus methodology with an international panel of 77 stakeholders to identify core domains for clinical research evaluating postdischarge outcomes of ARF survivors. The panel considered a preliminary list of 19 outcome domains, suggested eight additional domains for consideration, and ultimately reached the a priori consensus criteria for seven domains. Participation and retention of all stakeholder groups were excellent across both Delphi rounds. Core domains are defined as patient outcomes, healthrelated conditions, or aspects of health that are essential to evaluate within a specific field of research (20, 22) . Notably, the "essential" nature of core domains may vary by stakeholder group. Hence, assembling a consensus panel requires careful consideration. Clinical trials seek to assess the efficacy of interventions so that evidence-based treatment decisions can be made for individual patients. Current guidelines recommend that these treatment decisions be shared by patients, their families, and their clinicians (36) , making them the ultimate end users of research. However, the potential benefits of many COS have not been realized because the COS was not widely adopted by clinical researchers who perform trials (37, 38) . Unless research funders and journal editors require the use of COS, clinical researchers may not fully embrace them. Thus, to be successful, a COS must address outcomes that clinical researchers and their funders believe are important and that assist patients, their families, and clinicians in clinical decisionmaking (39) . We chose to include representatives from each of these stakeholder groups in our expert panel.
A recent systematic review of studies to achieve consensus on domains for COS found that only 16% of studies involved patients or caregivers in the consensus process (40) . An even smaller subset of these studies permitted patients or caregivers to participate in the prioritization of outcomes. The public is commonly excluded from Delphi panels because it can be challenging to identify appropriate patient and caregiver representatives, provide them with information tailored to their health literacy level, and incorporate them into the consensus process in a way that effectively uses and respects their area of expertise (41) (42) (43) . We purposefully recruited a sufficient number of patient/caregiver representatives to ensure that if most patient/caregivers rated a domain as not important (score ≤ 3), the domain would not meet our a priori consensus criteria, effectively giving patients and caregivers veto power. Clinicians and professional association representatives also had similar veto power given the size of their membership on the panel.
Stakeholder groups rated the vast majority of domains similarly. The three notable exceptions were the domains of financial impact on patients, healthcare resource utilization, and survival. These differences likely reflect distinct stakeholders' perspectives. After hospital discharge, ARF survivors experience high rates of hospital readmission and unemployment (2, 44) creating a direct financial burden for patients and caregivers. Similarly, clinical researchers were likely aware of mortality as a competing risk in evaluating functional outcomes (45, 46) and thus, universally viewed survival as essential whereas all caregivers on the panel had family members who were still alive years after ARF. Additional research is needed to determine whether the outcomes prioritized by caregivers of living ARF survivors differ from those of caregivers to ARF "survivors" who subsequently died shortly after hospital discharge. (24) 10 (29) 3 (16) 4 (24) 1 (25) a The consensus criteria for inclusion as a core domain were defined as ≥ 70% of all panel members rating a domain ≥ 7 and no more than 15% rating the domain ≤ 3 on a nine-point scale. Domains are ordered by the proportion of panel members rating the domain ≥ 7. b A total of four of 75 (5%) unique panel members ever selected "unable to score. " Number of panel members selecting unable to score by domain: survival, impact on family and/or caregiver, hearing, and management of complex medication regimens (1).
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The seven core domains identified in this study encompass aspects of physical, mental, and cognitive health. Notably, there were no core domains within social health (20, 47) . This might reflect an assumption that social health is largely determined by physical, cognitive, and mental health. However, the domain "satisfaction with life, or personal enjoyment," which was rated as critical by 69% of all panel members, including 82% of patients and caregivers, may reflect some aspects of social health. Notably, in previous pilot testing conducted before starting this project, the domain "health-related quality of life" received strong support (48) as a core domain, but many clinical researchers struggled to conceptualize this domain separate a The consensus criteria for inclusion as a core domain were defined as ≥ 70% of all panel members rating a domain ≥ 7 and no more than 15% rating the domain ≤ 3 on a nine-point scale. Domains are ordered by the proportion of panel members rating the domain ≥ 7.
b
In round 1 a total of 13 of 74 (18%) unique panel members ever selected "unable to score. " Number of panel members selecting unable to score by domain: working memory (8), executive function (10), memory (10), mental processing speed (6), attention (8), intelligence (6), alertness (8) , language/verbal fluency/ naming (7), and visuospatial ability or construction (7) . In round 2 a total of three of 75 (4%) unique panel members ever selected unable to score. Number of panel members selecting unable to score by domain: working memory, memory, mental processing speed, executive function, attention, intelligence, alertness, language/verbal fluency/naming, and visuospatial ability or construction (1) .
from its most well-known measurement instruments. Thus, we renamed the domain, which may have resulted in lower ratings among clinical researchers (vs patients/caregivers). Consistent with prior expert groups (6, 9, 48), we believe it is important to include a measure addressing survivors' subjective quality of life in a COS. We also encourage clinical researchers to consider assessing outcome domains that failed to meet the criteria for inclusion in a COS but were rated as critical by the vast majority of patient and caregiver representatives, such as financial impact on patients (88%) and impact on family and/ or caregivers (76%). Limiting invitations to representatives of U.S. federal research funding organizations combined with the 50% recruitment rate of these organizations represent a limitation of this study. After consultation with their internal ethics advisors, three-quarters of the nonparticipating federal organizations believed that participating in this NIH-funded research represented a conflict of interest. However, COS may be less likely to be adopted if research funders do not endorse and enforce them, making funder input into COS development desirable. We also cannot determine how our results would have differed if the Delphi panel had included patient and caregiver representatives from countries other than the four major English-speaking countries included in this project.
In conclusion, research evaluating postdischarge outcomes of ARF survivors has flourished without any deliberate effort to standardize the outcome domains assessed or the measurement instruments used. Via a rigorous modified Delphi process, an international panel of clinical researchers, clinicians, patients and caregivers, and U.S. federal research funding organizations reached consensus on the following seven core domains for clinical research evaluating postdischarge outcomes of ARF survivors: physical function, cognition, mental health, survival, pulmonary function, pain, and muscle and/or nerve function. These seven domains should always be measured in this field of research. The next step is achieving consensus on what measurement instruments should be used to assess these core domains.
